Development of non-sedating benzodiazepines with in vivo antischistosomal activity
Antimicrobial Agents and Chemotherapy · 04.09.2024 · 68 (9)
DOI: 10.1128/aac.00369-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 04.09.2024. Verfasst von Md Yeunus Mian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Benzodiazepines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NINDS NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
The neglected tropical disease schistosomiasis infects over 200 million people worldwide and is treated with just one broad-spectrum antiparasitic drug (praziquantel). Alternative drugs are needed in the event of emerging praziquantel resistance or treatment failure. One promising lead that has shown efficacy in animal models and a human clinical trial is the benzodiazepine meclonazepam, discovered by Roche in the 1970s. Meclonazepam was not brought to market because of dose-limiting sedative side effects. However, the human target of meclonazepam that causes sedation (GABA A Rs) is not orthologous to the parasite targets that cause worm death. Therefore, we were interested in whether the structure of meclonazepam could be modified to produce antiparasitic benzodiazepines that do not cause host sedation. We synthesized 18 meclonazepam derivatives with modifications at different positions on the benzodiazepine ring system and tested them for in vitro antiparasitic activity. This identified five compounds that progressed to in vivo screening in a murine model, two of which cured parasite infections with comparable potency to meclonazepam. When these two compounds were administered to mice that were run on the rotarod test, both were less sedating than meclonazepam. These findings demonstrate the proof of concept that meclonazepam analogs can be designed with an improved therapeutic index and point to the C3 position of the benzodiazepine ring system as a logical site for further structure–activity exploration to further optimize this chemical series.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
- Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
- Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Chemistry, University of Wisconsin Oshkosh, Oshkosh, Wisconsin, USA.
ORCID-Profile: Mostafa Zamanian, John D Chan
Förderung
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- NINDS NIH HHS
- NIDA NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Mian, M. Y., Sharmin, D., Mondal, P., Belayet, J. B., Hossain, M. M., McCusker, P., Ryan, K. T., Fedorov, A. Y., Green, H. A., Ericksen, S. S., Zamanian, M., Tiruveedhula, V. V. N. P. B., Cook, J. M., & Chan, J. D. (2024). Development of non-sedating benzodiazepines with in vivo antischistosomal activity. Antimicrobial Agents and Chemotherapy, 68(9). https://doi.org/10.1128/aac.00369-24
Vancouver
Mian MY, Sharmin D, Mondal P, Belayet JB, Hossain MM, McCusker P, et al. Development of non-sedating benzodiazepines with in vivo antischistosomal activity. Antimicrobial Agents and Chemotherapy. 2024;68(9). doi:10.1128/aac.00369-24
BibTeX
@article{Mian2024,
author = {Mian, Md Yeunus and Sharmin, Dishary and Mondal, Prithu and Belayet, Jawad Bin and Hossain, M Mahmun and McCusker, Paul and Ryan, Kaetlyn T and Fedorov, Alexander Y and Green, Heather A and Ericksen, Spencer S and Zamanian, Mostafa and Tiruveedhula, V V N Phani Babu and Cook, James M and Chan, John D},
title = {Development of non-sedating benzodiazepines with in vivo antischistosomal activity},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {9},
doi = {10.1128/aac.00369-24}
}
EUVIMED